LANCET 润色咨询

LANCET

出版年份:1823 年文章数:2161 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:2.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2013-11-28 匿名用户

    在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2014-07-30 匿名用户

    那些发评论和通讯小豆腐的就不要吹牛了,

    真心BS,谢谢读后感,搞个吧小病例,

    人家一篇10分的article抵上你这种垃圾100篇。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2024-10-12 ms8000000673612705 来自山东省

    请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2022-06-08 Spider

    偏重的研究方向:肿瘤
    经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。

    17

    展开17条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2022-01-16 17748b9278m

    审稿速度:1.0
    经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2021-12-29 衣谷

    SCI期刊是如何分区的?

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2023-03-24 采药者 来自广东省

    偏重的研究方向:公共卫生
    经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2023-06-01 4031828 来自河南省

    看看别人投稿的经验,自己学习一下

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter,已经3个月了,还没给回复,不知道是好还是坏,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了, <br> <br> 真心BS,谢谢读后感,搞个吧小病例, <br> <br> 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。有点不对头,时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向:肿瘤<br>经验分享:按照文章纸质版2周后编辑收稿算,我的评论型letter已经with editor3周了,不知道啥时出结果?好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1331, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0<br>经验分享:我来快乐地分享拒稿经验啦,投clinical picture,8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2912, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向:公共卫生;医学综合;糖尿病<br>经验分享:吓人!现在期刊分化会越来越严重,好的越来越好,差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1565, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1248, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向:公共卫生<br>经验分享:投了一篇分析型的letter,不是评论,带点研究性质,已经一个月了,还是with editor,做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验,自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:流行病学;综合期刊;医学综合<br>经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]
    2024-06-20 侠胆医心 来自伊利诺伊

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:流行病学;综合期刊;医学综合
    经验分享:NEJM在2023年度影响因子96.2,LANCET为98.4, BMJ为93.6,JAMA为63.1,表面看除JAMA外,三个名刊影响因子是差不多的,但是主要受前两年新冠相关文章的影响。到明年,BMJ和Lancet影响因子应该会较大幅度下降,但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大,这个地位不会改变的。

    0

共135条页码: 1/14页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分